BGI Genomics Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 3,143.45 million compared to CNY 4,517.5 million a year ago. Revenue was CNY 3,143.45 million compared to CNY 4,517.5 million a year ago.

Net income was CNY 70.35 million compared to CNY 747.1 million a year ago. Basic earnings per share from continuing operations was CNY 0.1683 compared to CNY 1.8273 a year ago. Diluted earnings per share from continuing operations was CNY 0.1682 compared to CNY 1.827 a year ago.